Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Cincinnati, Ohio 45229


The primary objective of this study is to determine the pharmacokinetic profile of a 50 mg/kg loading dose of intravenous levetiracetam (LEV) in term and late preterm infants with seizures. Secondary objectives are to evaluate the safety and efficacy of a 50 mg/kg loading dose of levetiracetam in term and preterm infants with seizures, and to obtain data on steady state drug levels of levetiracetam in neonates.


Inclusion Criteria: - Gestational age ≥ 32 weeks - Postnatal age ≤ 30 days - Birth weight ≥ 2000 grams - Admitted to the Neonatal Intensive Care Unit at Cincinnati Children's Hospital - Clinical or electrographic seizures of any etiology - Seizures or seizure prophylaxis requiring treatment with levetiracetam - Parental consent obtained Exclusion Criteria: - Infants with renal insufficiency indicated by serum creatinine > 2.0 at any time - Infants who have previously received levetiracetam - Parents refuse consent - Attending physician does not wish the infant to be enrolled in the study - Infants who are currently receiving an investigational drug



Primary Contact:

Principal Investigator
Stephanie Merhar, MD
Children's Hospital Medical Center, Cincinnati

Backup Contact:


Location Contact:

Cincinnati, Ohio 45229
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: August 31, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.